Efficacy and safety of low‐dose rifabutin‐based 7‐day triple therapy as a third‐ or later‐line Helicobacter pylori eradication regimen

BACKGROUND: Rifabutin‐based regimens are used as rescue therapy for refractory Helicobacter pylori infection; however, the duration for which treatment is required and side effects are concerning. This study assessed the efficacy and safety of 7‐day rifabutin, amoxicillin, and vonoprazan triple ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Inokuchi, Kazumi, Mori, Hideki, Matsuzaki, Juntaro, Hirata, Kenro, Harada, Yosuke, Saito, Yoshimasa, Suzuki, Hidekazu, Kanai, Takanori, Masaoka, Tatsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539484/
https://www.ncbi.nlm.nih.gov/pubmed/35644041
http://dx.doi.org/10.1111/hel.12900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539484/
https://www.ncbi.nlm.nih.gov/pubmed/35644041
http://dx.doi.org/10.1111/hel.12900

Ejemplares similares